"Collaboration is the sign of a true partnership. By collaborating early and often with participants and sites, we will more quicky improve the clinical trial technology ecosystem and ensure that solutions developed are user-centric and meet the needs of real participants and sites. High touch end-user engagement throughout the development lifecycle such as early insights, iterative design input, and robust training and support is a worthy investment to support the success of clinical trials.”
Tiffany McGinnis, senior consultant, Latham Biopharm Group